6α,3'-p-Dihydroxy Paclitaxel D5
| Product Name | 6α,3'-p-Dihydroxy Paclitaxel D5 |
|---|---|
| Alternate Names | Paclitaxel Stable Isotopes, Stable Isotopes of Paclitaxel |
| CAT No. | CS-EO-00582 |
| CAS No. | 157230-10-9 (Unlabeled) |
| Category | Stable Isotopes |
| Stock | Enquire |
| Mol. Wt. | 890.94 g/mol |
| Mol. For. | C47H46D5NO16 |
| Hazardous | This is not a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Paclitaxel |
| Canonical Smiles | CC1=C2C(C(=O)C3(C(C(C(C2(C)C)(CC1OC(=O)C(C(C4=CC=C(C=C4)O)NC(=O)C5=CC=CC=C5)O)O)OC(=O)C6=CC=CC=C6)C7(COC7C(C3O)O)OC(=O)C)C)OC(=O)C |
| InchIKey | NEGGNAWLXHJUEM-FJMWQILYSA-N |
| Inchl | InChI=1S/C47H51NO16/c1-23-30(62-43(58)33(52)32(26-17-19-29(51)20-18-26)48-41(56)27-13-9-7-10-14-27)21-47(59)40(63-42(57)28-15-11-8-12-16-28)36-45(6,38(55)35(61-24(2)49)31(23)44(47,4)5)37(54)34(53)39-46(36,22-60-39)64-25(3)50/h7-20,30,32-37,39-40,51-54,59H,21-22H2,1-6H3,(H,48,56)/t30-,32-,33+,34-,35+,36-,37-,39+,40-,45-,46+,47+/m0/s1 |
| IUPAC | [(1S,2S,3R,4S,7R,8S,9R,10S,12R,15S)-4,12-diacetyloxy-15-[(2R,3S)-3-benzamido-2-hydroxy-3-(4-hydroxyphenyl)propanoyl]oxy-1,8,9-trihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
6α,3'-p-Dihydroxy Paclitaxel D5 is a chemical compound that is commonly used in cancer treatment. It is a derivative of Paclitaxel, which is a natural compound extracted from the bark of the Pacific yew tree. Paclitaxel and its derivatives are known for their ability to interfere with the normal functioning of cancer cells by binding to the microtubules within the cells, preventing them from dividing and multiplying.
6α,3'-p-Dihydroxy Paclitaxel D5 is particularly effective in treating breast and ovarian cancers, as well as lung, bladder, and prostate cancers. It is administered through injection, usually in combination with other chemotherapy drugs, and is typically given over a period of several hours.
In terms of chemical information, 6α,3'-p-Dihydroxy Paclitaxel D5 is a semi-synthetic derivative of Paclitaxel that has been modified to increase its potency and reduce its side effects. It is a complex molecule with a molecular weight of 853.0 g/mol and a chemical formula of C47H51NO15.
While 6α,3'-p-Dihydroxy Paclitaxel D5 can be effective in treating cancer, it can also have significant side effects, including nausea, vomiting, hair loss, and an increased risk of infection. Patients receiving this treatment must be carefully monitored to ensure that they are able to tolerate the drug and that their cancer is responding to the treatment.
Get an Instant Quote
Related Compounds
Paclitaxel-D5 (Benzoyloxy) | Paclitaxel-D5 (Benzoylamine) |